{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:45:07Z","timestamp":1774442707532,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"crossref","award":["(2018ZX10302104)"],"award-info":[{"award-number":["(2018ZX10302104)"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aims to evaluate specific risk factors influencing prognosis of HIV-infected patients with toxoplasma encephalitis (TE) in order to develop a prognostic risk scoring system for them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a six-center retrospective study of hospitalized HIV\/TE patients. Data including six-week mortality after diagnosis, baseline characteristics, clinical features, laboratory tests and radiological characteristics of eligible patients were assimilated for risk model establishing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, the six-week mortality among 94 retrospective cases was 11.7% (11\/94). Seven specific risk factors, viz. time from symptom onset to presentation, fever, dizziness, CD4+ T-cell counts, memory deficits, patchy brain lesions, and disorders of consciousness were calculated to be statistically associated with mortality. A criterion value of \u20189\u2019 was selected as the optimal cut-off value of the established model. The AUC of the ROC curve of this scoring model was 0.976 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The sensitivity and specificity of the risk scoring model was 100.0 and 86.9%, respectively, which were 81.8 and 94.1% of this scoring model in the verification cohort, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The developed scoring system was established with simple risk factors, which also allows expeditious implementation of accurate prognostication, and appropriate therapeutic interventions in HIV-infected patients with TE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05651-x","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T07:04:34Z","timestamp":1607065474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Qiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Tong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"5651_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1051\/parasite\/2019006","volume":"26","author":"M Rouatbi","year":"2019","unstructured":"Rouatbi M, Amairia S, Amdouni Y, Boussaadoun MA, Ayadi O, Al-Hosary AAT, et al. Toxoplasma gondii infection and toxoplasmosis in North Africa: a review. Parasite. 2019;26:6. https:\/\/doi.org\/10.1051\/parasite\/2019006.","journal-title":"Parasite"},{"key":"5651_CR2","first-page":"2","volume-title":"Toxoplasmic Encephalitis. Edition: 1, Chapter: 1, Publisher: Avid Science, Editors: Avid Science. Encephalitis","author":"M McFarland","year":"2016","unstructured":"McFarland M, Bartlett M, Davis P. Toxoplasmic Encephalitis. Edition: 1, Chapter: 1, Publisher: Avid Science, Editors: Avid Science. Encephalitis; 2016. p. 2\u201352."},{"key":"5651_CR3","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.[EB\/OL]. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf [accessed May 16, 2020]."},{"key":"5651_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1756-0500-6-146","volume":"6","author":"HN Luma","year":"2013","unstructured":"Luma HN, Tchaleu BC, Mapoure YN, Temfack E, Doualla MS, Halle MP, et al. Toxoplasma encephalitis in HIV\/AIDS patients admitted to the Douala general hospital between 2004 and 2009: a cross sectional study. BMC Res Notes. 2013;6:146. https:\/\/doi.org\/10.1186\/1756-0500-6-146.","journal-title":"BMC Res Notes"},{"issue":"6","key":"5651_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bjid.2012.08.015","volume":"16","author":"AB Lib\u00f3rio","year":"2012","unstructured":"Lib\u00f3rio AB, Silva GB Jr, Silva CG, Filho FL, Neto AS, Okoba W, et al. Hyponatremia, acute kidney injury, and mortality in HIV-related toxoplasmic encephalitis. Braz J Infect Dis. 2012;16(6):558\u201363. https:\/\/doi.org\/10.1016\/j.bjid.2012.08.015.","journal-title":"Braz J Infect Dis"},{"issue":"17","key":"5651_CR6","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1212\/WNL.0b013e3182704040","volume":"79","author":"R Sonneville","year":"2012","unstructured":"Sonneville R, Schmidt M, Messika J, Hssain AA, da Daniel S, Klein IF, et al. Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. Neurology. 2012;79(17):1762\u20136. https:\/\/doi.org\/10.1212\/WNL.0b013e3182704040.","journal-title":"Neurology"},{"key":"5651_CR7","unstructured":"The National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, [EB\/OL].(2019\/6\/26)[2020\/5\/16] https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent-opportunistic-infection\/322\/toxoplasma-gondii-encephalitis."},{"issue":"10","key":"5651_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/apc.2005.19.626","volume":"19","author":"JE Vidal","year":"2005","unstructured":"Vidal JE, Hernandez AV, de Oliveira AC, Dauar RF, Barbosa SP Jr, Focaccia R, et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDs. 2005;19(10):626\u201334. https:\/\/doi.org\/10.1089\/apc.2005.19.626.","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"5651_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pmr.2016.12.003","volume":"28","author":"BC Eapen","year":"2017","unstructured":"Eapen BC, Georgekutty J, Subbarao B, Bavishi S, Cifu DX. Disorders of consciousness. Phys Med Rehabil Clin N Am. 2017;28(2):245\u201358. https:\/\/doi.org\/10.1016\/j.pmr.2016.12.003.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"4","key":"5651_CR10","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","volume":"4","author":"ZD Wang","year":"2017","unstructured":"Wang ZD, Wang SC, Liu HH, Ma HY, Li ZY, Wei F, et al. Prevalence and burden of toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4(4):e177\u201388. https:\/\/doi.org\/10.1016\/S2352-3018(17)30005-X.","journal-title":"Lancet HIV"},{"issue":"3","key":"5651_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00281-015-0487-3","volume":"37","author":"TA Landrith","year":"2015","unstructured":"Landrith TA, Harris TH, Wilson EH. Characteristics and critical function of CD8+ T cells in the toxoplasma-infected brain. Semin Immunopathol. 2015;37(3):261\u201370. https:\/\/doi.org\/10.1007\/s00281-015-0487-3.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"5651_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1469-0691.2007.01683.x","volume":"13","author":"C Hoffmann","year":"2007","unstructured":"Hoffmann C, Ernst M, Meyer P, Wolf E, Rosenkranz T, Plettenberg A, et al. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and toxoplasma gondii-specific immune responses. Clin Microbiol Infect. 2007;13(5):510\u20135. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01683.x.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"5651_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hipo.22354","volume":"24","author":"JC Augustinack","year":"2014","unstructured":"Augustinack JC, van der Kouwe AJ, Salat DH, Benner T, Stevens AA, Annese J, et al. H.M.'s contributions to neuroscience: a review and autopsy studies. Hippocampus. 2014;24(11):1267\u201386. https:\/\/doi.org\/10.1002\/hipo.22354.","journal-title":"Hippocampus"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05651-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T07:06:19Z","timestamp":1607065579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05651-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5651"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05651-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-68395\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-68395\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-68395\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"29 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the institutional review board of the Chongqing Public Health Medical Center (No. 2019\u2013003-02-KY). The institutional review board waived the requirement for written informed consent, since the present study was retrospective, and all patient data were analyzed in anonymity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"923"}}